LONG COVID
Clinical trials for LONG COVID explained in plain language.
Never miss a new study
Get alerted when new LONG COVID trials appear
Sign up with your email to follow new studies for LONG COVID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug trial aims to stop COVID's lasting lung damage
Disease control OngoingThis study is testing whether the drug sirolimus can prevent permanent lung scarring (fibrosis) in people hospitalized with severe COVID-19 pneumonia. Hospitalized patients will be randomly assigned to receive different doses of sirolimus or standard care alone. Researchers will …
Matched conditions: LONG COVID
Phase: PHASE2, PHASE3 • Sponsor: University of Chicago • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for long COVID heart damage: trial tests combo therapy to halt progression
Disease control OngoingThis study is testing whether a combination of two existing drugs can protect the heart in people with Long COVID who have developed heart inflammation. Researchers will give 279 participants either the active medication or a placebo for 16 weeks to see if it reduces symptoms lik…
Matched conditions: LONG COVID
Phase: PHASE3 • Sponsor: Valentina Puentmann • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Could a single infusion ease the burden of long COVID?
Disease control OngoingThis study is testing whether a one-time infusion of a lab-made antibody (AER002) can help people with Long COVID feel better. About 30 adults with persistent symptoms after a COVID-19 infection will receive either the antibody treatment or a placebo. Researchers will track chang…
Matched conditions: LONG COVID
Phase: PHASE2 • Sponsor: Michael Peluso, MD • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New test seeks to detect lingering virus in long COVID patients
Diagnosis ENROLLING_BY_INVITATIONThis study is testing a new, non-invasive method to help diagnose Long COVID. Researchers will use a single-session procedure that measures the body's bioelectrical responses to see if patterns can indicate a persistent viral presence. The goal is to evaluate whether this approac…
Matched conditions: LONG COVID
Phase: NA • Sponsor: Oncology Center,Ministry Of Heath,Uzbekistan • Aim: Diagnosis
Last updated Mar 20, 2026 14:48 UTC
-
Can light and melatonin fix long COVID sleep woes?
Symptom relief OngoingThis study is testing whether tailored light therapy or melatonin supplements can help people with Long COVID who are struggling with severe sleep problems like insomnia or daytime sleepiness. It's a Phase 2 trial involving 470 participants across multiple centers. The goal is to…
Matched conditions: LONG COVID
Phase: PHASE2 • Sponsor: Duke University • Aim: Symptom relief
Last updated Mar 30, 2026 14:32 UTC
-
Can new therapies help long COVID patients walk again without crashing?
Symptom relief OngoingThis study is testing different treatments to help people with Long COVID who get very tired and feel worse after even light exercise. It will enroll 360 participants across multiple centers to see if certain interventions can help them walk longer, do more daily activities, and …
Matched conditions: LONG COVID
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Mar 30, 2026 14:32 UTC
-
Could a party drug ease long COVID's debilitating symptoms?
Symptom relief ENROLLING_BY_INVITATIONThis small pilot study is exploring whether ketamine, a medication used for anesthesia and depression, can help relieve the persistent fatigue and cognitive problems ('brain fog') experienced by people with Long COVID. Twenty adults will receive four ketamine injections over two …
Matched conditions: LONG COVID
Phase: PHASE2 • Sponsor: University of Texas at Austin • Aim: Symptom relief
Last updated Mar 30, 2026 14:31 UTC
-
New 'Window into your Body' therapy aims to ease long COVID breathing struggles
Symptom relief OngoingThis study is testing a new therapy called Cognitive Muscular Therapy (CMT) to help people with Long COVID who have trouble breathing. The therapy uses a special system to show patients how their breathing muscles are working in real-time, combined with physical training. Researc…
Matched conditions: LONG COVID
Phase: NA • Sponsor: University of Salford • Aim: Symptom relief
Last updated Mar 30, 2026 14:31 UTC
-
Could a weight loss drug ease long COVID's debilitating fatigue?
Symptom relief OngoingThis study is testing whether the medication tirzepatide (brand name Zepbound) can reduce symptoms of Long COVID, especially severe fatigue. It involves 1,000 adults in the U.S. with Long COVID who will be randomly assigned to take either the real medication or a placebo pill for…
Matched conditions: LONG COVID
Phase: PHASE2 • Sponsor: Scripps Translational Science Institute • Aim: Symptom relief
Last updated Mar 30, 2026 14:28 UTC
-
New tech rehab aims to rebuild brain and body after stroke, MS, Parkinson's, and long COVID
Symptom relief OngoingThis study is testing new rehabilitation exercises that combine physical and mental tasks, like walking while solving a puzzle, to help people with stroke, multiple sclerosis, Parkinson's disease, or long COVID. The goal is to see if these 'dual-task' exercises, often supported b…
Matched conditions: LONG COVID
Phase: NA • Sponsor: I.R.C.C.S. Fondazione Santa Lucia • Aim: Symptom relief
Last updated Mar 23, 2026 15:14 UTC
-
Mind over matter: new therapy trial targets long COVID suffering
Symptom relief OngoingThis study is testing whether a psychological therapy called Balance Acceptance and Commitment Therapy (ACT) can improve quality of life for people with long COVID. Researchers are comparing the therapy against standard self-help information in 196 UK adults who have had COVID sy…
Matched conditions: LONG COVID
Phase: NA • Sponsor: King's College London • Aim: Symptom relief
Last updated Mar 16, 2026 15:25 UTC
-
New hope for long COVID's exhausting sleep disorder
Symptom relief OngoingThis study is testing different treatments to help people with Long COVID who struggle with severe sleep problems like extreme daytime sleepiness and insomnia. About 361 participants will be assigned to receive either an active treatment or a placebo based on their specific sleep…
Matched conditions: LONG COVID
Phase: PHASE2 • Sponsor: Duke University • Aim: Symptom relief
Last updated Mar 02, 2026 15:21 UTC
-
Could yogurt and kimchi ease long COVID? mayo clinic investigates gut connection
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to see if eating a diet high in fermented foods like yogurt, kefir, and kimchi can change the mix of bacteria in the gut (the microbiome) of people with long COVID. Researchers at Mayo Clinic will enroll 40 adults with long COVID and randomly assign half to eat 6+…
Matched conditions: LONG COVID
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC
-
VA probes why long COVID zaps Veterans' energy
Knowledge-focused OngoingThis study aims to understand why veterans with Long COVID experience such severe and persistent fatigue. Researchers are measuring muscle function and oxygen use to find the cause. They are also testing if a simple, once-a-week home exercise program is safe and feasible for this…
Matched conditions: LONG COVID
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC
-
Scientists probe immune link in mysterious chronic illnesses
Knowledge-focused OngoingThis study aims to understand if a specific problem with the body's immune T-cells is causing symptoms in people with long COVID, chronic Lyme disease, or ME/CFS (chronic fatigue syndrome). Researchers will observe 160 people, including healthy volunteers, by taking blood samples…
Matched conditions: LONG COVID
Sponsor: ViraxBio Labs • Aim: Knowledge-focused
Last updated Feb 27, 2026 15:18 UTC